CRP and atherosclerosis: Specifically, it seeks to measure carotid intima-media thickness (c-IMT) to estimate the prevalence of subclinical atherosclerosis, assess Flow-mediated dilatation (FMD) of the brachial artery to determine the prevalence of endothelial dysfunction, and correlate these findings with inflammatory biomarkers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).